Finafta
NDC 58593-783, Benzocaine, Glycerin, liquid, from Efficient Laboratories Inc..
- Product NDC
- 58593-783
- Status
- Listed
- Labeler
- Efficient Laboratories Inc.
- Dosage form
- LIQUID
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M022
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58593-783 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BENZOCAINE5 mg/100mL
- GLYCERIN33 mg/100mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Chemical Allergen [EPC]; Standardized Chemical Allergen [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58593-783-15 | 58593078315 | 15 mL in 1 BOTTLE, WITH APPLICATOR (58593-783-15) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58593-783 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58593-783 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58593-783. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.